Browsing Tag
SARS-CoV-2
50 posts
BNT162 COVID-19 vaccine candidate : US govt signs $2bn supply deal with Pfizer and BioNTech
Pfizer and BioNTech have bagged a $1.95 billion deal with the US government for supplying 100 million doses…
July 22, 2020
COV001 clinical trial results : Oxford vaccine ChAdOx1 nCoV-19 triggers strong immune response
COV001 clinical trial results : AstraZeneca and Oxford University said that interim results from the phase 1/2 COV001…
July 20, 2020
BNT162b1 and BNT162b2 Covid-19 vaccine candidates get FDA fast track status
Pfizer and BioNTech said that BNT162b1 and BNT162b2, two vaccine candidates developed to give protection against the SARS-CoV-2…
July 14, 2020
Gilead Sciences announces Veklury EU approval for COVID-19 treatment
Veklury EU approval : Gilead Sciences said that Veklury (remdesivir) has been given conditional marketing authorization from the…
July 6, 2020
Noxopharm launches NOXCOVID-1 clinical trial of Veyonda across Europe
Noxopharm, an Australian clinical-stage pharma company, has started the phase 1 NOXCOVID-1 clinical trial for Veyonda in Europe…
July 1, 2020
Imperial College begins human trial of coronavirus vaccine candidate COVAC1
Imperial College London said that it has dosed the first healthy volunteer with its COVAC1 coronavirus vaccine candidate,…
June 24, 2020
Merck completes acquisition of Austrian vaccine developer Themis Bioscience
Pharma giant Merck has wrapped up its previously announced acquisition of Austrian vaccine developer Themis Bioscience. The Austrian…
June 19, 2020
Lilly Covid drug trial : US pharma giant launches phase 3 trial of baricitinib
Lilly Covid drug trial : Eli Lilly and Company has enrolled the first patient in a phase 3…
June 15, 2020
Sinovac Biotech CoronaVac COVID-19 vaccine candidate succeeds in phase 1/2 trial
Sinovac Biotech said that the phase 1/2 clinical trial for its coronavirus vaccine candidate CoronaVac has delivered positive…
June 14, 2020
Intranasal COVID-19 vaccine : Intravacc, WBVR and Utrecht University join forces for vaccine development
Dutch vaccine maker Intravacc has forged a partnership with Wageningen Bioveterinary Research (WBVR) and Utrecht University in the…
June 5, 2020